Consultations
Science that moves decisions forward
We are a specialized consulting practice working at the intersection of life sciences, regulatory strategy, and scientific communication. Our team brings deep bench experience in cell therapy, gene therapy, immunology, and oncology to every engagement, whether that means building your investor narrative, assembling your scientific team, or modernizing your R&D workflows.
Practice Areas
Strategy & Capital Raising
We build the scientific argument behind your fundraise. From Series A pitch decks to investor white papers, our work translates mechanism of action, preclinical data, and regulatory strategy into finance-ready materials that close rounds. We also develop competitive landscape analyses, milestone mapping tied to value inflection points, and executive summaries for board and partnering conversations.
Typical deliverables: investor decks, white papers, competitive intelligence reports, strategic narratives, board materials.
Regulatory & Preclinical Program Support
We support early stage programs with FDA-aligned documentation for cell and gene therapies moving toward IND submission. This is the scientific writing and data interpretation layer that feeds into your regulatory strategy: preclinical study rationale, pharmacology and biodistribution summaries, technical briefing documents for pre-IND meetings, and response support for FDA information requests. We work across discovery, preclinical, CMC, and regulatory functions to ensure scientific alignment throughout.
Typical deliverables: IND-enabling documentation, nonclinical study reports, FDA briefing documents, cross-functional alignment support.
Grant Development
We develop NIH, ARPA-H, and foundation grant applications from concept through submission, with deep experience in cell therapy, gene therapy, immunology, and regenerative medicine. For ARPA-H submissions, we work within the Heilmeier Framework. For NIH mechanisms (R01, R21, SBIR/STTR), we handle Specific Aims, full Research Strategy sections, experimental design consultation, biosketches, budget justification, and resubmission responses to reviewer critiques.
Typical deliverables: complete grant applications, Specific Aims pages, Research Strategy sections, resubmission packages.
Scientific Communications & Intellectual Property
We produce manuscripts, literature reviews, white papers, and technical reports across immunology, hematology, oncology, cell therapy, gene therapy, and aging biology. For founders and scientists building a public profile, we ghostwrite thought leadership content for Substack, company blogs, and conference presentations. Our patent support, delivered in collaboration with a licensed patent agent, covers invention disclosure development, scientific substantiation, and technical drafting through provisional and non-provisional filings.
Typical deliverables: research manuscripts, review articles, white papers, patent applications, thought leadership content.
Scientific Recruiting & Team Assembly
Early stage biotech companies often face a compounding problem: they need specialized scientific talent but lack the internal expertise to evaluate candidates or define the right team structure. We help solve both sides. Drawing on our network across cell therapy, gene therapy, and immuno-oncology, we identify and evaluate scientific talent, assemble project-specific teams, and provide the scientific judgment to match the right people to the right problems. This is not traditional headhunting. It is team design informed by someone who understands the science.
Typical engagements: team structure advisory, candidate evaluation, project-specific team assembly, scientific hiring support.
AI Integration for Life Sciences
We help biotech and biopharma teams integrate AI tools into their existing scientific workflows. This is not generic technology consulting. We focus on practical, high-impact applications where domain expertise determines whether the implementation actually works: automated literature surveillance and competitive intelligence, AI-assisted regulatory document drafting, data analysis pipeline design for multi-omics datasets, and knowledge management systems that make institutional expertise searchable. Every integration is scoped by scientists who understand both the tools and the biology.
Typical engagements: workflow assessment, tool selection and implementation, AI-assisted document automation, custom pipeline development.
Advisory, Speaking & Workshops
We provide scientific advisory services for preclinical program strategy, experimental design, assay development, and go/no-go decisions. For organizations and conferences, we offer speaking engagements and workshops on cell and gene therapy, longevity science, technology governance, and the evolving relationship between AI and drug development. Workshops can be tailored for scientific teams, investors, or mixed audiences.
Typical engagements: scientific advisory boards, keynote presentations, team workshops, experimental design consultation.
English–Arabic Scientific Translation
We provide English to Arabic translation for medical and scientific content, anchored by clinical training and native Arabic fluency. This covers clinical documents, patient-facing materials, regulatory summaries, and technical manuscripts. For organizations entering or operating in the MENA region, we also provide scientific content localization consulting to ensure materials meet regional expectations without losing technical precision.
Typical deliverables: translated clinical documents, localized regulatory materials, Arabic scientific content development.
Who We Are
Our team is a group of PhDs and MDs with hands-on experience across academic research and industry R&D in cell therapy, gene therapy, immunology, and regenerative medicine. Collectively, we have supported programs from early discovery through IND-enabling stages at leading biotech companies, with research backgrounds spanning hematopoietic stem cell biology, clonal hematopoiesis, single-cell transcriptomics, and translational immunology.
This combination of bench-level expertise and strategic communication experience is what enables us to engage with the underlying science, not just the surface of a document or a slide. Every engagement is led by a senior scientist with direct domain knowledge, ensuring rigor throughout.
Therapeutic & Technical Focus
Cell Therapy & iPSC Platforms
Reprogramming, directed differentiation, hypoimmune engineering, release assays, tumorigenicity, cGMP readiness
Gene Therapy
AAV vector optimization, liver-directed programs, biodistribution, IND-enabling strategy, CMC documentation
Immunology, Autoimmunity & Immuno-Oncology
CAR-T, engineered immune cells, checkpoint biology, tumor microenvironment, humanized mouse models, autoimmune disease mechanisms and therapeutic targets
Hematology & Aging Biology
HSC biology, clonal hematopoiesis (CHIP), immune aging, longevity mechanisms
Multi-Omics & Data Integration
scRNA-seq, CITE-seq, spatial transcriptomics, optical genome mapping, ddPCR, translational data interpretation
AI in Drug Development
Literature mining, regulatory automation, workflow integration, multi-omics analysis pipelines
Regenerative Medicine
Tissue engineering, wound healing, organ repair, stem cell derived therapeutics, translational program design
Antibody & Protein Therapeutics
Monoclonal antibodies, bispecifics, targeted protein degradation, biologics strategy, partnering materials
How We Work
Scope
Every engagement starts with a clear brief. We define deliverables, timelines, and success criteria before any work begins. For new clients, we are happy to provide a short sample or outline so you can evaluate fit before committing.
Execute
For longer engagements, we build in structured check-ins so you can course correct before final delivery. Communication is direct. We flag scope changes, timeline risks, and data gaps early. If something falls outside our expertise, we say so and connect you to the right resource.
Deliver
Turnaround depends on scope. A pitch deck or white paper typically takes one to three weeks. A full grant application runs three to six weeks. Shorter deliverables such as literature reviews, technical summaries, or editing work can often be completed within a week.
Ready to discuss your project?
Tell us about your timeline, scope, and what you are trying to accomplish. We will let you know if it is a good fit and how we can help.
consulting@albidayat.com